東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Polypharmacy: Patterns and Policy Pr...

Do, Duy Hoang.

Linked to FindBook

Google Book

Amazon

博客來

Polypharmacy: Patterns and Policy Propositions.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Polypharmacy: Patterns and Policy Propositions./
Author:	Do, Duy Hoang.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2020,
Description:	230 p.
Notes:	Source: Dissertations Abstracts International, Volume: 81-10, Section: B.
Contained By:	Dissertations Abstracts International81-10B.
Subject:	Demography. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27828517
ISBN:	9798607319243

Polypharmacy: Patterns and Policy Propositions.
Do, Duy Hoang.

Polypharmacy: Patterns and Policy Propositions. - Ann Arbor : ProQuest Dissertations & Theses, 2020 - 230 p.

Source: Dissertations Abstracts International, Volume: 81-10, Section: B.

Thesis (Ph.D.)--University of Pennsylvania, 2020.

This item must not be sold to any third party vendors.

Sixty percent of U.S. adults report frequent use of prescription medications, a prevalence that is higher than ever before. Although medications are lifesaving when used properly, they can produce side effects ranging from minor problems like dizziness to severe events such as an increased risk of cancer. Polypharmacy - a phenomenon typically defined as concurrent use of multiple medications - may present unique risks for medication side effects, amplifying the effects of each of the medication in a set. Given the growing medication use across the country, this dissertation examined the causes of polypharmacy and the consequences of concurrent use of medications with side effects on population health and health care use. The first chapter provided background information on polypharmacy and medication side effects. The second chapter used the National Health and Nutrition Examination Survey (NHANES) to investigate whether and how the introduction of Medicare Part D, a large and sudden change to health care financing for Medicare beneficiaries, affected medication use for older adults. While Part D increased the use of lifesaving medications, it also increased polypharmacy. The third chapter used the NHANES to show that concurrent use of three or more medications with cognitive impairment side effects among U.S. older adults increased three-fold in the past two decades. Individuals who used three or more such medications experienced increased risks of cognitive deficits compared to non-users. The fourth chapter used the Medical Expenditure Panel Survey (MEPS) to document a growth of 36% in the concurrent use of at least three medications with mental health side effects among U.S. adults in the past two decades. Concurrent use of these medications was associated with an increase in psychiatric symptoms and the use/costs of mental health services. In the fifth chapter, I discussed how the processes of medicalization and pharmaceuticalization contributed to rising medication use and disparities in such use, which in turn had implications for population-level health disparities. Collectively, these findings shed light on patterns and disparities in population health associated with polypharmacy and speak directly to the role of broader social, economic, cultural, and institutional inequalities in generating and maintaining health disparities.

ISBN: 9798607319243Subjects--Topical Terms:

614991
Demography.
Subjects--Index Terms:

Polypharmacy

Polypharmacy: Patterns and Policy Propositions.
LDR:03481nmm a2200337 4500 001 2273118
005 20201105110346.5
008 220629s2020 ||||||||||||||||| ||eng d
020 $a 9798607319243
035 $a (MiAaPQ)AAI27828517
035 $a AAI27828517
040 $a MiAaPQ $c MiAaPQ
100 1 $a Do, Duy Hoang. $3 3550551
245 1 0 $a Polypharmacy: Patterns and Policy Propositions.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2020
300 $a 230 p.
500 $a Source: Dissertations Abstracts International, Volume: 81-10, Section: B.
500 $a Advisor: Schnittker, Jason.
502 $a Thesis (Ph.D.)--University of Pennsylvania, 2020.
506 $a This item must not be sold to any third party vendors.
506 $a This item must not be added to any third party search indexes.
520 $a Sixty percent of U.S. adults report frequent use of prescription medications, a prevalence that is higher than ever before. Although medications are lifesaving when used properly, they can produce side effects ranging from minor problems like dizziness to severe events such as an increased risk of cancer. Polypharmacy - a phenomenon typically defined as concurrent use of multiple medications - may present unique risks for medication side effects, amplifying the effects of each of the medication in a set. Given the growing medication use across the country, this dissertation examined the causes of polypharmacy and the consequences of concurrent use of medications with side effects on population health and health care use. The first chapter provided background information on polypharmacy and medication side effects. The second chapter used the National Health and Nutrition Examination Survey (NHANES) to investigate whether and how the introduction of Medicare Part D, a large and sudden change to health care financing for Medicare beneficiaries, affected medication use for older adults. While Part D increased the use of lifesaving medications, it also increased polypharmacy. The third chapter used the NHANES to show that concurrent use of three or more medications with cognitive impairment side effects among U.S. older adults increased three-fold in the past two decades. Individuals who used three or more such medications experienced increased risks of cognitive deficits compared to non-users. The fourth chapter used the Medical Expenditure Panel Survey (MEPS) to document a growth of 36% in the concurrent use of at least three medications with mental health side effects among U.S. adults in the past two decades. Concurrent use of these medications was associated with an increase in psychiatric symptoms and the use/costs of mental health services. In the fifth chapter, I discussed how the processes of medicalization and pharmaceuticalization contributed to rising medication use and disparities in such use, which in turn had implications for population-level health disparities. Collectively, these findings shed light on patterns and disparities in population health associated with polypharmacy and speak directly to the role of broader social, economic, cultural, and institutional inequalities in generating and maintaining health disparities.
590 $a School code: 0175.
650 4 $a Demography. $3 614991
650 4 $a Statistics. $3 517247
653 $a Polypharmacy
653 $a Prescription medications
690 $a 0938
690 $a 0463
710 2 $a University of Pennsylvania. $b Demography. $3 2096107
773 0 $t Dissertations Abstracts International $g 81-10B.
790 $a 0175
791 $a Ph.D.
792 $a 2020
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=27828517